ABSTRACT
INTRODUCTION
By reducing the incidence of restenosis (a major disadvantage of bare-metal stent technology) and by treating patients who have drug-eluting stents (DES) with modern antiplatelet agents, the use of percutaneous coronary intervention (PCI) with DES has been thought to challenge coronary artery bypass grafting (CABG) for the treatment of patients with multivessel disease and left main stenosis. Consequently, the practice of "off-label" PCI outside the current guideline indications has increased in recent years and is thought to account for 30% to 60% of a routine interventional cardiology practice [Kappetein 2006; Brodie 2008; Ko 2009 ]. Comparisons of PCI with CABG for multivessel disease in various randomized and registry studies have nevertheless revealed strong evidence that CABG remains superior to PCI, even when DES are used [Briguori 2007; Javaid 2007; Brener 2008; Hannan 2008] . Although the identifi cation of distinctive predictors of adverse early or long-term outcomes in PCI with DES is still under discussion, there is wide consensus that the complexity of coronary artery disease (CAD), although diffi cult to measure, strongly correlates with the advent of major adverse cardiac and cerebrovascular events (MACCE) after PCI.
The SYNTAX score was recently developed as a comprehensive angiographic scoring tool to quantify the complexity of CAD and to assist in patient selection and risk stratifi cation [Valgimigli 2007] . Although the experience with this score has been limited to date, it is a promising classifi cation system for the detailed description of the anatomical severity of CAD. It was recently demonstrated that PCI patients presenting with SYNTAX scores >26 had a signifi cantly higher postprocedural MACCE rate and that the SYNTAX score independently predicted outcome [Valgimigli 2007 ]. These fi ndings were recently confi rmed with the randomized population of the SYNTAX study ]; however, the early and late prognostic impacts of the SYNTAX score for CABG patients are still unknown. The aim of the present study was therefore to evaluate whether a complex pathology of the coronary arterial tree expressed by the SYNTAX score was a risk factor for an adverse long-term outcome after coronary artery surgery, as has already been shown for PCI patients at 1 year after the procedure [Valgimigli 2007] .
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METHODS AND PATIENTS
We retrospectively analyzed 200 consecutive patients who had been referred for coronary surgery in 2002 and for whom the original coronary angiograms were available. The study protocol was approved by the local institutional review board. After exclusion of patients with previous cardiac surgery, an emergency indication, stent implantation within 6 months before surgery, incomplete fi les, or impossibility of gaining follow-up, we were able to include 154 patients in the study.
Data for demographic, intraoperative, perioperative parameters had been prospectively recorded in the hospital database. Additionally, the SYNTAX score was retrospectively calculated from the preoperative angiograms by a team of 3 experienced cardiac surgeons. These surgeons were not the same surgeons who performed the operations in 2002. The SYNTAX score is a comprehensive anatomical assessment derived from various preexisting classifi cations. In brief, each lesion producing ≥50% luminal obstruction in vessels ≥1.5 mm in diameter is defi ned according to the modifi ed American Heart Association coronary tree segment classification and is separately scored with respect to bifurcational, trifurcational, or aortic ostial localization; chronic occlusion; vessel tortuosity; lesion length; calcifi cation; and thrombus formation. Finally, the score of each lesion is added to obtain the patient's total SYNTAX score. Thus, higher SYNTAX scores are indicative of complex coronary artery disease.
A yearly patient follow-up to at least 5 years was obtained by written or telephone contact and was focused on major cardiac events and recurrent angina. MACCE included death from all causes, myocardial infarction, repeat revascularization, and cerebral stroke. The 5-year follow-up rate was 100%.
Continuous variables were estimated as the mean ± SD, and the data were evaluated by 1-way analysis of variance. Discrete variables were reported as counts and/or percentages, and differences were assessed by means of the chi-square test or the Fisher exact test, as indicated.
In a fi rst step, we performed univariate and multivariate Cox regression analysis that included as potentially infl uencing factors the EuroSCORE, the SYNTAX score, arterial hypertension, smoking status, New York Heart Association functional class, Canadian Cardiovascular Society class, diabetes mellitus, and previous stent implantation.
In a second step, we divided the patients into 3 SYNTAX score groups (≤18, >18-26, and >26). These divisions were based on the distribution in our study population and on a recently published PCI series by Valgimigli and colleagues [2007] , but they varied from those of the data analysis used in the SYNTAX study . Cumulative event rates (overall survival, occurrence of MACCE, and angina) were estimated by the Kaplan-Meier method and compared by means of log-rank tests. Data were analyzed with SPSS software (version 13.0; SPSS, Chicago, IL, USA) and Microsoft Excel software (Redmond, WA, USA).
RESULTS
Demographic and perioperative data for all of the patients and the different SYNTAX score subgroups are summarized in Tables 1 and 2 . The groups showed no signifi cant differences for any of the criteria. 
Thirty-Day Outcome
The overall 30-day mortality rate was 2.6% (3 patients). Causes of death were low cardiac output (2 patients) and respiratory failure (1 patient). Table 3 summarizes the major perioperative complications.
Long-term Outcome
The total follow-up time was 685 patient-years. The cumulative survival rate was 94.8% (95% confi dence interval [CI], 91.3%-98.3%) at 1 year and 84.1% (95% CI, 78.0%-90.1%) at 5 years.
Independent predictors of death during follow-up were a high preoperative EuroSCORE (odds ratio [OR], 1.8/point; 95% CI, 1.4-2.3; P = .0001), current smoking (OR, 29.0; 95% CI, 4.6-182.4; P = .0001), and ex-smoker (OR, 10.2; 95% CI, 2.3-46.1; P = .02) (Figure 1 ). Independent risk factors for MACCE during follow-up were a higher EuroSCORE (OR, 1.5/point; 95% CI, 1.2-1.9; P = .0001), current smoking (OR, 21.9; 95% CI, 4.7-101.3; P = .0001), ex-smoker (OR, 8.9; 95% CI, 2.5-30.9; P = .001), and New York Heart Association class III or IV at the time of operation (OR, 6.7; 95% CI, 1.6-29.1; P = .0001).
The SYNTAX score subgroups demonstrated no significant differences with respective to survival, freedom from MACCE, or freedom from MACCE and angina recurrence (Figure 2 ).
DISCUSSION
Data from randomized controlled trials comparing DES to bare-metal stents have shown signifi cant reductions in repeat intervention with the use of DES and with comparable Th e Heart Surgery Forum #2009-1157
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death and myocardial infarction rates [Stettler 2007 ]. These improvements have led to expanding the use of PCI in patients with complex coronary anatomy, even though most randomized trials exclude such patients. According to contemporary guidelines, the suitability for a particular revascularization approach is dependent on a number of factors. The interventional cardiologist is particularly interested in the coronary anatomy (eg, the presence of chronic total occlusions, bifurcation disease, tortuosity, and calcifi cation), whereas the surgeon is more concerned with the presence of comorbidities (eg, chronic obstructive pulmonary disease, renal impairment, recent stroke) and the availability of suitable graft conduits, all of which may negatively affect surgical outcome. The SYNTAX score was developed by a team of cardiologists and cardiac surgeons. It was designed to assess the anatomical complexity and, to a lesser extent, the functionality of the coronary artery bed. The intention was to make patients comparable with respect to their coronary pathology. Thus far, the role of the SYNTAX score for therapeutic decisions and/or patient guidance has not been clarifi ed. It is particularly unclear whether the SYNTAX score can provide a means of prognostic signifi cance for patients after CABG surgery and whether therapeutic strategies (eg, surveillance intervals) can be deduced from the score. The SYNTAX score has been shown to be an independent predictor of MACCE after PCI [Valgimigli 2007] . A higher SYNTAX score can also predict periprocedural myocardial injury after PCI [van Gaal 2008] .
It remains unclear, however, what kind of coronary pathology is the key predictor of poor outcome in PCI patients. Additionally, the critical SYNTAX score limit for PCI treatment is unknown. Post hoc analyses of SYNTAX score subgroups may help defi ne coronary characteristics that favor either CABG or PCI in patients with 3-vessel/left main disease.
No long-term results regarding the relation between SYNTAX score and postoperative outcome have yet been reported. Two recent studies provide insight into 1-year results after cardiac surgery with respect to the SYNTAX score. Lemesle and colleagues [2009] found no difference in MACCE rates after 1 year for different SYNTAX score groups in patients with 3-vessel disease and concluded that the SYNTAX score had no prognostic value after coronary surgery. On the other hand, Birim and colleagues [2009] identifi ed the SYNTAX score as a good predictor for the occurrence of MACCE within 1 year after CABG surgery in patients with left main disease.
In a larger group of randomized patients-the surgical arm of the SYNTAX study-the 1-year MACCE rate was demonstrated not to be infl uenced by the SYNTAX score ].
The intention of our study was to correlate the SYNTAX score with long-term results after cardiac surgery. A clear predictive value of the SYNTAX score (as has been shown for postprocedural outcome after PCI) also could not be found for patients after surgical revascularization in our study. Furthermore, patients with a higher SYNTAX score demonstrated no trend toward a higher risk for the occurrence of MACCE or angina recurrence during a 5-year postoperative period. On the other hand, the well-known risk factors for postsurgical outcome, mainly refl ected by the EuroSCORE, had a strong prognostic signifi cance.
In conclusion, our study found no relationship between a higher SYNTAX score and a worse postoperative long-term outcome. It provides more support for the assumption that surgical revascularization is an excellent therapeutic option, independent of the complexity of CAD. Of course, this conclusion needs to be confi rmed with long-term results from larger trials, such as the SYNTAX trial.
LIMITATIONS
The study was retrospective in nature because the SYNTAX score was developed only recently, and the intention was to obtain a 5-year follow-up. The number of patients was relatively small. A larger trial might demonstrate additional signifi cant differences. The patient population consisted only of patients who were referred for surgery and for whom PCI was not considered as an alternative option. The SYNTAX score was calculated by cardiac surgeons. Although they were independent from the surgeries, a possible bias cannot be completely excluded. Furthermore, the patient population included not only patients with de novo 3-vessel CAD, and therefore comparability to the population of the SYNTAX trial is limited. Figure 1 . Results of univariate linear regression analysis for major adverse cardiac and cerebrovascular events after 5 years. PAOD indicates peripheral artery occlusive disease; COLD, chronic obstructive lung disease; Crea, creatinine; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; EF, ejection fraction; ES, EuroSCORE.
